RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Arcutis Biotherapeutics - Stock

Arcutis Biotherapeutics Stocks 2024

Arcutis Biotherapeutics Stocks

69.31 M

Ticker

ARQT

ISIN

US03969K1088

WKN

A2PYWE

In 2024, Arcutis Biotherapeutics had 69.31 M outstanding stocks, a 0% change from the 69.31 M stocks in the previous year.

The Arcutis Biotherapeutics Stocks history

YEARNUMBER OF STOCKS (undefined USD)
2029e69.31
2028e69.31
2027e69.31
2026e69.31
2025e69.31
2024e69.31
202369.31
202255.03
202149.41
202035.67
201936.63
201836.63
201736.63

Arcutis Biotherapeutics Aktienanalyse

What does Arcutis Biotherapeutics do?

Arcutis Biotherapeutics Inc. is a California-based biopharmaceutical company specializing in the development and commercialization of innovative dermatological therapies. Arcutis Biotherapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Stocks Details

Evaluating Arcutis Biotherapeutics's Shares Outstanding

Arcutis Biotherapeutics's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.

Year-to-Year Comparison

Tracking the changes in Arcutis Biotherapeutics’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.

Impact on Investments

For investors, understanding Arcutis Biotherapeutics’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.

Interpreting Changes in Shares Outstanding

Variances in Arcutis Biotherapeutics’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.

Frequently Asked Questions about Arcutis Biotherapeutics Stock

How many stocks are there of Arcutis Biotherapeutics?

The current number of stocks of Arcutis Biotherapeutics is 69.31 M undefined.

What does Number of Shares / OutstandingShares mean?

The outstanding shares (or issued shares) of Arcutis Biotherapeutics are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.

How has the number of shares of Arcutis Biotherapeutics evolved in recent years?

The number of shares of Arcutis Biotherapeutics has increased by 0% gestiegen compared to last year.

What does the number of shares mean for investors?

The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.

Why does the number of stocks fluctuate?

There are various factors that can lead to a change. Arcutis Biotherapeutics as a company can issue new shares, carry out stock splits or reverse splits.

Does the number of shares have an impact on the performance of Arcutis Biotherapeutics?

There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

How much dividend does Arcutis Biotherapeutics pay?

Over the past 12 months, Arcutis Biotherapeutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Arcutis Biotherapeutics is expected to pay a dividend of 0 USD.

What is the dividend yield of Arcutis Biotherapeutics?

The current dividend yield of Arcutis Biotherapeutics is .

When does Arcutis Biotherapeutics pay dividends?

Arcutis Biotherapeutics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Arcutis Biotherapeutics?

Arcutis Biotherapeutics paid dividends every year for the past 0 years.

What is the dividend of Arcutis Biotherapeutics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Arcutis Biotherapeutics located?

Arcutis Biotherapeutics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Arcutis Biotherapeutics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Arcutis Biotherapeutics from 6/12/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/12/2024.

When did Arcutis Biotherapeutics pay the last dividend?

The last dividend was paid out on 6/12/2024.

What was the dividend of Arcutis Biotherapeutics in the year 2023?

In the year 2023, Arcutis Biotherapeutics distributed 0 USD as dividends.

In which currency does Arcutis Biotherapeutics pay out the dividend?

The dividends of Arcutis Biotherapeutics are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Arcutis Biotherapeutics

Our stock analysis for Arcutis Biotherapeutics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Arcutis Biotherapeutics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.